IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients

This publication has 25 references indexed in Scilit:

• Efficacy of 24 weeks treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C infected with genotype 1 and low pretreatment viremia
  Journal of Hepatology, 2006
• Treatment With Pegylated Interferon and Ribavarin in Hcv Infection With Genotype 2 Or 3 for 14 Weeks: A Pilot Study
  Hepatology, 2004
• Peginterferon-α2a and Ribavirin Combination Therapy in Chronic Hepatitis C
  Annals of Internal Medicine, 2004
• IL-10 haplotypes as possible predictors of spontaneous clearance of HCV infection
  Cytokine, 2004
• Early Virologic Response to Treatment With Peginterferon Alfa–2B Plus Ribavirin in Patients With Chronic Hepatitis C
  Hepatology, 2003
• Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
  New England Journal of Medicine, 2002
• Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
  The Lancet, 2001
• Interleukin-10 and the Interleukin-10 Receptor
  Annual Review of Immunology, 2001
• Early prediction of response in interferon monotherapy and in interferon-ribavirin combination therapy for chronic hepatitis C: HCV RNA at 4 weeks versus ALT
  Journal of Hepatology, 1999
• Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C
  Gastroenterology, 1996